, Tracking Stock Market Picks
Enter Symbol:
Regeneron Pharmaceuticals, Inc. (REGN) [hlAlert]

up 67.92 %

Regeneron Pharmaceuticals, Inc. (REGN) rated Buy with price target $387 by BofA/Merrill

Posted on: Wednesday,  Feb 12, 2014  8:25 AM ET by BofA/Merrill

BofA/Merrill rated Buy Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) on 02/12/2014, when the stock price was $320.38. Since
then, Regeneron Pharmaceuticals, Inc. has gained 67.93% as of 01/27/2016's recent price of $538.00.
If you would have followed this BofA/Merrill's recommendation on REGN, you would have gained 67.92% of your investment in 714 days.

Regeneron Pharmaceuticals Inc. is a biopharmaceutical company that discovers, develops, and intends to commercialize therapeutic drugs for thetreatment of serious medical conditions. Regeneron's platform technologies include Targeted GenomicsTM, FunctionomicsTM, and Designer Protein TherapeuticsTM. Regeneron has drugs in clinical and preclinical development for the potential treatment of obesity, rheumatoid arthritis, cancer, allergies, asthma, amyotrophic lateral sclerosis, constipating conditions, ischemia, and other diseases and disorders. (PRESS RELEASE)

Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
2/12/2014 8:25 AM Buy
320.38 387.00
as of 10/17/2014
1 Week up  7.60 %
1 Month up  2.93 %
3 Months up  24.70 %
1 YTD up  15.37 %

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy